Use of Chimeric Antigen Receptor Engineered T-cells to Treat Neuroblastoma.
Institution:
Children’s Hospital of PhiladelphiaResearcher(s):
Nathan SinghGrant Type:
POST Program GrantsYear Awarded:
2012Type of Childhood Cancer:
Neuroblastoma
Fighting childhood cancer, one cup at a time.
